Literature DB >> 33545035

A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells.

Sijin Cheng1, Ziyi Li1, Ranran Gao1, Baocai Xing2, Yunong Gao3, Yu Yang1, Shishang Qin1, Lei Zhang1, Hanqiang Ouyang4, Peng Du5, Liang Jiang4, Bin Zhang6, Yue Yang7, Xiliang Wang1, Xianwen Ren1, Jin-Xin Bei8, Xueda Hu1, Zhaode Bu9, Jiafu Ji10, Zemin Zhang11.   

Abstract

Tumor-infiltrating myeloid cells (TIMs) are key regulators in tumor progression, but the similarity and distinction of their fundamental properties across different tumors remain elusive. Here, by performing a pan-cancer analysis of single myeloid cells from 210 patients across 15 human cancer types, we identified distinct features of TIMs across cancer types. Mast cells in nasopharyngeal cancer were found to be associated with better prognosis and exhibited an anti-tumor phenotype with a high ratio of TNF+/VEGFA+ cells. Systematic comparison between cDC1- and cDC2-derived LAMP3+ cDCs revealed their differences in transcription factors and external stimulus. Additionally, pro-angiogenic tumor-associated macrophages (TAMs) were characterized with diverse markers across different cancer types, and the composition of TIMs appeared to be associated with certain features of somatic mutations and gene expressions. Our results provide a systematic view of the highly heterogeneous TIMs and suggest future avenues for rational, targeted immunotherapies.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LAMP3+ dendritic cells; mast cells; pan-cancer analysis; single-cell RNA-sequencing; tumor-associated macrophages; tumor-infiltrating myeloid cells

Year:  2021        PMID: 33545035     DOI: 10.1016/j.cell.2021.01.010

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  106 in total

Review 1.  Myeloid cell-targeted therapies for solid tumours.

Authors:  Sangeeta Goswami; Swetha Anandhan; Deblina Raychaudhuri; Padmanee Sharma
Journal:  Nat Rev Immunol       Date:  2022-06-13       Impact factor: 53.106

2.  A Prognostic Model of Colon Cancer Based on the Microenvironment Component Score via Single Cell Sequencing.

Authors:  Yawei Liu; Xiao Liu; Qiaoling Xu; Xiangyu Gao; Enqiang Linghu
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

3.  Discovering dominant tumor immune archetypes in a pan-cancer census.

Authors:  Alexis J Combes; Bushra Samad; Jessica Tsui; Nayvin W Chew; Peter Yan; Gabriella C Reeder; Divyashree Kushnoor; Alan Shen; Brittany Davidson; Andrea J Barczak; Michael Adkisson; Austin Edwards; Mohammad Naser; Kevin C Barry; Tristan Courau; Taymour Hammoudi; Rafael J Argüello; Arjun Arkal Rao; Adam B Olshen; Cathy Cai; Jenny Zhan; Katelyn C Davis; Robin K Kelley; Jocelyn S Chapman; Chloe E Atreya; Amar Patel; Adil I Daud; Patrick Ha; Aaron A Diaz; Johannes R Kratz; Eric A Collisson; Gabriela K Fragiadakis; David J Erle; Alexandre Boissonnas; Saurabh Asthana; Vincent Chan; Matthew F Krummel
Journal:  Cell       Date:  2021-12-27       Impact factor: 41.582

Review 4.  Clinical relevance of tumour-associated macrophages.

Authors:  Mikael J Pittet; Olivier Michielin; Denis Migliorini
Journal:  Nat Rev Clin Oncol       Date:  2022-03-30       Impact factor: 66.675

Review 5.  The role of dendritic cells in cancer and anti-tumor immunity.

Authors:  Ariel E Marciscano; Niroshana Anandasabapathy
Journal:  Semin Immunol       Date:  2021-05-20       Impact factor: 11.130

Review 6.  Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage.

Authors:  James Isaacs; Aaron C Tan; Brent A Hanks; Xiaofei Wang; Kouros Owzar; James E Herndon; Scott J Antonia; Steven Piantadosi; Mustafa Khasraw
Journal:  Clin Cancer Res       Date:  2021-07-26       Impact factor: 12.531

7.  Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy.

Authors:  Marie Siwicki; Nicolas A Gort-Freitas; Marius Messemaker; Ruben Bill; Jeremy Gungabeesoon; Camilla Engblom; Rapolas Zilionis; Christopher Garris; Genevieve M Gerhard; Anna Kohl; Yunkang Lin; Angela E Zou; Chiara Cianciaruso; Evangelia Bolli; Christina Pfirschke; Yi-Jang Lin; Cecile Piot; John E Mindur; Nilesh Talele; Rainer H Kohler; Yoshiko Iwamoto; Mari Mino-Kenudson; Sara I Pai; Claudio deVito; Thibaud Koessler; Doron Merkler; Alexander Coukos; Alexandre Wicky; Montserrat Fraga; Christine Sempoux; Rakesh K Jain; Pierre-Yves Dietrich; Olivier Michielin; Ralph Weissleder; Allon M Klein; Mikael J Pittet
Journal:  Sci Immunol       Date:  2021-07-02

8.  Single-cell analyses reveal suppressive tumor microenvironment of human colorectal cancer.

Authors:  Yan Mei; Weiwei Xiao; Hao Hu; Guanming Lu; Lingdan Chen; Zhun Sun; Mengdie Lü; Wenhui Ma; Ting Jiang; YuanHong Gao; LiRen Li; Gong Chen; Zifeng Wang; Hanjie Li; Duojiao Wu; Pinghong Zhou; Qibin Leng; Guangshuai Jia
Journal:  Clin Transl Med       Date:  2021-06

Review 9.  How Machine Learning and Statistical Models Advance Molecular Diagnostics of Rare Disorders Via Analysis of RNA Sequencing Data.

Authors:  Lea D Schlieben; Holger Prokisch; Vicente A Yépez
Journal:  Front Mol Biosci       Date:  2021-06-01

10.  p38 MAPK signaling in M1 macrophages results in selective elimination of M2 macrophages by MEK inhibition.

Authors:  Daniel Baumann; Jennifer Drebant; Tanja Hägele; Luisa Burger; Clara Serger; Claudia Lauenstein; Przemyslaw Dudys; Gerrit Erdmann; Rienk Offringa
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.